Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Vycor Medical Q3 2026 Results: Net Income $738, Down 85.0% YoY

Vycor Medical reported a net loss of $1,442 for the nine months ended September 30, 2026, a significant improvement from the $9,740 loss in the prior year period. Despite a decrease in total revenue to $1.29 million, the company achieved positive operating income of $80,083 and remains focused on managing its substantial stockholders' deficiency of $4.41 million.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue0.40.5
Gross profit0.40.5
Profit before tax0.00.0
Net income0.00.0
EPS (diluted, $ a share)$-0.00$-0.00

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year-85.0%
Revenue, year on year-19.2%
Gross margin85.1%
Operating margin6.6%
Source

10-Q filed with the SEC, OTC: VYCO. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Vycor Medical Inc: key numbers

Share price
$0.0440Close, Nov 13
Market cap
$1.47M
Shares outstanding
33.37MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Vycor Medical Inc

All →
6:58 AM ET 8-K
Financial Results

Vycor Medical Financial Results

Vycor Medical reported Q3 2026 revenue of $0.41M, a 19% decrease year-over-year, primarily due to higher-than-normal bulk orders in the prior year period. Despite the revenue decline, the company maintained a high gross margin of 85% and reported a nine-month operating profit of $80,083.

Term
Q3 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.